Product Description
a novel polymer-linked diaminocyclohexyl platinum chemotherapeutic agent
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Unknown
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Access
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Ovarian Cancer
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT00415298 |
CDR0000520463 | N/A |
Unknown status |
Head and Neck Cancer|Squamous Cell Carcinoma |
None |
2019-03-21 |
Treatments |
|
2010-020030-25 |
2010-020030-25 | P2 |
Completed |
Ovarian Cancer |
2013-11-13 |
2022-03-13 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|